Solazyme Announces Transition of Dr. Harrison Dillon, Co-Founder and
President to Strategic Advisor Role
SOUTH SAN FRANCISCO, Calif. -- September 5, 2013
Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company,
announced today that Harrison Dillon, Ph.D., the company’s co-founder and
President, has decided to step down from his full-time position and shift to a
long-term consulting role focused on further developing the breadth of the
technology platform and advising on intellectual property strategy.
“The experience of starting a company -- taking an idea, developing a
technology and building a team to commercialize it -- has vastly exceeded my
expectations. It has also been intense and incredibly focused. I wouldn’t
trade the experience for anything, but I am looking forward now to spending
more time with my family and recharging,” said Dr. Dillon.
“Harrison’s drive and integrity as well as his scientific creativity and legal
skills were key in the formation and development of Solazyme. We are grateful
to him for his leadership over the past 10 years, and I am personally grateful
to Harrison for his friendship since our earliest days in college. Harrison
will continue on this journey with Solazyme as an advisor, consultant,
shareholder and friend as we commercialize this technology platform globally,”
said Jonathan Wolfson, CEO of Solazyme.
“We have just scratched the surface of what Solazyme’s technology platform
will mean to the world. While I am looking forward to a change of pace, I
remain committed to helping Solazyme achieve its goals and I am supremely
confident in the team running the company,” said Dr. Dillon. As part of his
transition, Dr. Dillon has also stepped down from the company’s Board of
Solazyme, Inc.(SZYM) is a renewable oil and bioproducts company that
transforms a range of low-cost plant-based sugars into high-value oils and
food ingredients. Headquartered inSouth San Francisco,Solazyme'srenewable
products can replace or enhance oils derived from the world's three existing
sources — petroleum, plants and animal fats. Initially,Solazymeis focused on
commercializing its products into three target markets: (1) chemicals and
fuels, (2) nutrition and (3) skin and personal care.
Solazyme®, theSolazymelogo and other trademarks or service names are
trademarks ofSolazyme, Inc.
Genet Garmendi, 650-780-4777
VP of Corporate Communications
Brainerd Communicators, Inc.
Jeff Majtyka, 212-986-6667
Brad Edwards, 212-986-6667
Press spacebar to pause and continue. Press esc to stop.